# Rocket Pharmaceuticals, Inc.: filings

RCKT · Nasdaq · CIK 1281895 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rckt.md) · [Financials](/companies/rckt/financials.md) · [Filings](/companies/rckt/filings.md) · [Insiders](/companies/rckt/insiders.md)

## Reports and events: 238 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 341, 8-K 148, 144 108, 3 45, 10-Q 35, SC 13G/A 32, 424B5 21, CORRESP 21, SC 13G 20, SC 13D/A 16, UPLOAD 15, DEFA14A 13, 10-K 12, DEF 14A 12, EFFECT 9, SCHEDULE 13G/A 9, S-8 8, 3/A 7, 4/A 7, S-1/A 6, S-3 5, 5 4, ARS 4, FWP 4, SC 13D 4, 425 3, 8-K/A 3, PRE 14A 3, 424B4 2, 8-A12B 2, CT ORDER 2, S-1 2, S-3/A 2, S-3ASR 2, SCHEDULE 13G 2, 144/A 1, 25-NSE 1, 305B2 1, 424B2 1, 424B3 1, 8-A12B/A 1, CERT 1, CERTNAS 1, D 1, D/A 1, DEFM14A 1, DEL AM 1, DRS 1, DRS/A 1, POS AM 1, PREM14A 1, PRER14A 1, PX14A6G 1, RW 1, S-1MEF 1, S-3MEF 1, S-4 1, S-4/A 1, SC TO-C 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 17:15 ET | [8-K](/filings/0001140361-26-038818.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-038818 |
| 2026-09-15 | 07:06 ET | [8-K](/filings/0001140361-26-036563.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-036563 |
| 2026-08-27 | 16:06 ET | [8-K](/filings/0001140361-26-034689.md) | 5.02 Departure or appointment of officers or directors | 0001140361-26-034689 |
| 2026-08-10 | 16:17 ET | [8-K](/filings/0001140361-26-032028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-032028 |
| 2026-08-10 | 16:05 ET | [10-Q](/filings/0001193125-26-342348.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342348 |
| 2026-08-03 | 07:41 ET | [8-K](/filings/0001140361-26-030568.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-030568 |
| 2026-06-30 | 17:16 ET | [8-K](/filings/0001140361-26-026982.md) | 5.02 Departure or appointment of officers or directors | 0001140361-26-026982 |
| 2026-06-12 | 07:10 ET | [8-K](/filings/0001140361-26-024997.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-024997 |
| 2026-05-21 | 06:02 ET | [8-K](/filings/0001140361-26-022311.md) | 5.07 Shareholder vote results | 0001140361-26-022311 |
| 2026-05-07 | 16:45 ET | [8-K](/filings/0001140361-26-019573.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-019573 |
| 2026-05-07 | 16:06 ET | [10-Q](/filings/0001193125-26-211873.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211873 |
| 2026-04-28 | 07:34 ET | [8-K](/filings/0001140361-26-017275.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-017275 |
| 2026-04-06 | 16:06 ET | [DEF 14A](/filings/0001140361-26-013335.md) | Proxy statement, period 2026-05-20 | 0001140361-26-013335 |
| 2026-03-27 | 07:32 ET | [8-K](/filings/0001140361-26-011573.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-011573 |
| 2026-03-10 | 17:24 ET | [8-K](/filings/0001140361-26-008853.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-008853 |
| 2026-02-26 | 16:21 ET | [8-K](/filings/0001140361-26-006981.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-006981 |
| 2026-02-26 | 16:06 ET | [10-K](/filings/0001193125-26-076551.md) | Annual report, period 2025-12-31 | 0001193125-26-076551 |
| 2025-11-06 | 16:06 ET | [10-Q](/filings/0001193125-25-269474.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269474 |
| 2025-11-06 | 16:04 ET | [8-K](/filings/0001140361-25-040774.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-040774 |
| 2025-10-14 | 07:09 ET | [8-K](/filings/0001140361-25-038030.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-038030 |
| 2025-10-03 | 16:30 ET | [8-K](/filings/0001140361-25-037237.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-037237 |
| 2025-10-03 | 07:02 ET | [8-K](/filings/0001140361-25-037163.md) | 8.01 Other events | 0001140361-25-037163 |
| 2025-09-29 | 17:19 ET | [8-K](/filings/0001140361-25-036556.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-036556 |
| 2025-09-17 | 16:15 ET | [8-K](/filings/0001140361-25-035251.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-035251 |
| 2025-08-25 | 16:05 ET | [8-K](/filings/0001140361-25-032502.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-032502 |
| 2025-08-20 | 07:11 ET | [8-K](/filings/0001140361-25-032012.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-032012 |
| 2025-08-07 | 16:06 ET | [10-Q](/filings/0000950170-25-104996.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104996 |
| 2025-08-07 | 16:02 ET | [8-K](/filings/0001140361-25-029582.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-029582 |
| 2025-07-24 | 07:10 ET | [8-K](/filings/0001140361-25-027032.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-027032 |
| 2025-07-23 | 16:29 ET | [8-K](/filings/0001140361-25-026946.md) | 2.05 Exit or disposal costs | 0001140361-25-026946 |
| 2025-07-17 | 07:46 ET | [8-K](/filings/0001140361-25-026132.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-026132 |
| 2025-07-11 | 16:38 ET | [8-K](/filings/0001140361-25-025673.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-025673 |
| 2025-06-18 | 16:52 ET | [8-K](/filings/0001140361-25-022996.md) | 5.07 Shareholder vote results | 0001140361-25-022996 |
| 2025-05-27 | 07:40 ET | [8-K](/filings/0001140361-25-020409.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-020409 |
| 2025-05-15 | 16:57 ET | [8-K](/filings/0001140361-25-019326.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-019326 |
| 2025-05-08 | 16:12 ET | [8-K](/filings/0001140361-25-017958.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-017958 |
| 2025-05-08 | 16:02 ET | [10-Q](/filings/0000950170-25-066898.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066898 |
| 2025-04-30 | 16:14 ET | [DEF 14A](/filings/0001140361-25-016656.md) | Proxy statement, period 2025-06-18 | 0001140361-25-016656 |
| 2025-04-29 | 16:23 ET | [8-K](/filings/0001140361-25-016338.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-016338 |
| 2025-04-07 | 17:24 ET | [8-K](/filings/0001140361-25-012621.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-012621 |
| 2025-02-27 | 16:48 ET | [8-K](/filings/0001140361-25-006302.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-006302 |
| 2025-02-27 | 16:01 ET | [10-K](/filings/0000950170-25-029002.md) | Annual report, period 2024-12-31 | 0000950170-25-029002 |
| 2025-01-28 | 21:28 ET | [8-K](/filings/0001140361-25-002103.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-002103 |
| 2024-12-16 | 19:51 ET | [SC 13D/A](/filings/0001193125-24-279899.md) | Ownership report, active investor, amended | 0001193125-24-279899 |
| 2024-12-12 | 16:02 ET | [8-K](/filings/0001140361-24-049137.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-049137 |
| 2024-12-05 | 16:14 ET | [8-K](/filings/0001140361-24-048475.md) | 5.02 Departure or appointment of officers or directors | 0001140361-24-048475 |
| 2024-11-18 | 16:15 ET | [8-K](/filings/0001140361-24-047166.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-047166 |
| 2024-11-07 | 16:45 ET | [10-Q](/filings/0000950170-24-123459.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123459 |
| 2024-11-07 | 16:20 ET | [8-K](/filings/0001140361-24-045670.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-045670 |
| 2024-09-11 | 16:06 ET | [8-K](/filings/0001140361-24-040837.md) | 5.02 Departure or appointment of officers or directors | 0001140361-24-040837 |

Page 1 of 5. [Older](/companies/rckt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:58 ET. No prices; not investment advice.